PTC Therapeutics Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Klein Matthew B. unloaded Company’s shares for reported $0.37 million on Dec 31 ’24. In the deal valued at $45.16 per share,8,279 shares were sold. As a result of this transaction, Klein Matthew B. now holds 217,528 shares worth roughly $10.12 million.
Then, Klein Matthew B. bought 8,279 shares, generating $373,876 in total proceeds.
Before that, Almstead Neil Gregory sold 69,550 shares. PTC Therapeutics Inc shares valued at $3,620,895 were divested by the CHIEF TECHNICAL OPS OFFICER at a price of $52.06 per share. As a result of the transaction, Almstead Neil Gregory now holds 86,202 shares, worth roughly $4.01 million.
Morgan Stanley upgraded its PTC Therapeutics Inc [PTCT] rating to an Overweight from a an Equal-weight in a research note published on December 13, 2024; the price target was increased to $67 from $45. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in early December from “a Sector perform” to “an Outperform”. Robert W. Baird started covering the stock on September 04, 2024. It rated PTCT as “an Outperform”.
Price Performance Review of PTCT
On Friday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock jump 1.44% to $46.54. Over the last five days, the stock has gained 1.53%. PTC Therapeutics Inc shares have risen nearly 3.10% since the year began. Nevertheless, the stocks have risen 70.91% over the past one year. While a 52-week high of $54.16 was reached on 01/02/25, a 52-week low of $23.58 was recorded on 01/02/25. SMA at 50 days reached $44.56, while 200 days put it at $36.10.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 46.00, which if violated will result in even more drops to 45.47. On the upside, there is a resistance level at 46.90. A further resistance level may holdings at 47.27. The Relative Strength Index (RSI) on the 14-day chart is 53.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.64%. Stochastics %K at 28.95% indicates the stock is a holding.
How much short interest is there in PTC Therapeutics Inc?
A steep rise in short interest was recorded in PTC Therapeutics Inc stocks on 2024-12-13, dropping by 82839.0 shares to a total of 4.59 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 4.67 million shares. There was a decline of -1.8%, which implies that there is a negative sentiment for the stock.
